GlobeNewswire Inc.··The Portnoy Law FirmRezolute Stock Plunges 87% After Failed Drug Trial, Securities Probe Launched
Rezolute's lead drug candidate failed Phase 3 trials, triggering massive stock collapse and securities fraud investigation by Portnoy Law Firm.
RZLTsecurities fraud investigationstock price collapse